Drug intelligence / Profile preview

terazosin + hydrochlorothiazide

Development stage
Unknown
Lead developer
Abbott
Modality
Small Molecules
Administration
Oral
01

Overview

Terazosin + hydrochlorothiazide is a combination of two antihypertensive agents used to manage high blood pressure. Terazosin is an alpha-1 adrenergic receptor blocker that relaxes smooth muscle in blood vessels, leading to vasodilation and reduced peripheral vascular resistance. Hydrochlorothiazide is a thiazide diuretic that reduces blood volume by increasing renal excretion of sodium and water, thereby lowering blood pressure. The combination provides additive or synergistic effects for the treatment of hypertension, especially when monotherapy with either agent is insufficient. This combination may also attenuate some adverse metabolic effects associated with thiazide diuretics[1][3][8].

02

Targets

ADRA1A (α1A)SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)

Beyond the preview

Go deeper on terazosin + hydrochlorothiazide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on terazosin + hydrochlorothiazide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call